|
As leaders in the field of Pediatric Blood and Marrow Stem Cell Transplantation, Dr. Ka Wah Chan, Dr. Renee Madden and Dr. Veronica Jude have more than 50 years combined experience.
The Pediatric Blood and Marrow Stem Cell Transplant program is the regional transplant program for South Texas.
As one of the busiest pediatric transplant programs in the United States, it performs 40 to 50 transplants per year.
The Pediatric Blood and Marrow Stem Cell Transplant team performs related and unrelated donor transplants with expertise in using unrelated donor umbilical cord blood transplants for patients who lack a related donor. More than 200 unrelated cord blood transplants have been performed since 2002.
The Pediatric Blood and Marrow Stem Cell Transplant program is the first in North America accredited by the Foundation for the Accreditation of Cell Therapy (FACT) and has remained accredited ever since.
Leukemias, Lymphomas, Bone and soft tissue tumors, Brain tumors, Bone marrow failure syndrome, Red blood cell disorders, White blood cell disorders, Platelet disorders, Immunodeficiency syndromes, Histiocytic disorder, Inborn errors of metabolism, Child Life, Psychology, Nutrition, Physiotherapy/Occupational Therapy, Pet Visitation
Physicians, Nurse Practitioners and Hospital Staff
Pediatric Stem Cell Transplant Research
We conduct clinical research in conjunction with the following organizations:
-
Children's Oncology Group (COG)
-
Bone Marrow Transplant Clinical Trials Network (BMT CTN)
-
Pediatric Stem Cell Transplant Consortium
-
Center for International Bone Marrow Transplant Registry (CIBMTR)
-
Eurocord Registry
-
Multi-institutional clinical transplant trials with other leading pediatric stem cell transplant programs
-
Industry-sponsored clinical trials
Read about patients who received blood and marrow stem cell transplants.
The Pediatric Stem Cell Transplant program is the first in North America accredited by the Foundation for the Accreditation of Cell Therapy (FACT) and has remained accredited ever since.
The program is also approved by the Children's Oncology Group (COG) for patients enrolled in COG clinical trials.
|
